Metromile Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Metromile in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Metromile stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MILE, but not buy additional shares or sell existing shares.
View analyst ratings for Metromile or view top-rated stocks.

2 Wall Street analysts have issued 1 year price objectives for Metromile's stock. Their MILE stock forecasts range from $2.05 to $7.00. On average, they predict Metromile's share price to reach $4.53 in the next twelve months. This suggests a possible upside of 381.4% from the stock's current price.
View analysts' price targets for Metromile or view top-rated stocks among Wall Street analysts.

Metromile's stock was trading at $2.19 at the beginning of the year. Since then, MILE stock has decreased by 57.1% and is now trading at $0.94.
View the best growth stocks for 2022 here.

Metromile is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Metromile.

Metromile, Inc. (NASDAQ:MILE) issued its earnings results on Tuesday, May, 10th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.17. The company earned $20.70 million during the quarter, compared to analyst estimates of $11.60 million. Metromile had a negative trailing twelve-month return on equity of 57.64% and a negative net margin of 130.53%.
View Metromile's earnings history.

Some companies that are related to Metromile include Universal Insurance (UVE), Tiptree (TIPT), GAINSCO (GANS), Global Indemnity Group (GBLI), NI (NODK), Root (ROOT), Trean Insurance Group (TIG), Greenlight Capital Re (GLRE), Maiden (MHLD), Omnichannel Acquisition (OCA), Kingsway Financial Services (KFS), Deep Yellow (DYLLF), Heritage Insurance (HRTG), United Insurance (UIHC) and First Acceptance (FACO).
View all of MILE's competitors.

Metromile trades on the NASDAQ under the ticker symbol "MILE."

Metromile's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.88%), Vanguard Group Inc. (2.43%), State Street Corp (2.28%), Ergoteles LLC (1.86%), Goldman Sachs Group Inc. (1.64%) and Bank of Montreal Can (1.00%).
View institutional ownership trends for Metromile.

MILE stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., JPMorgan Chase & Co., Keebeck Alpha LP, Simplex Trading LLC, Nantahala Capital Management LLC, Jane Street Group LLC, UBS Group AG, and Cutler Group LP.
View insider buying and selling activity for Metromile or view top insider-selling stocks.

MILE stock was acquired by a variety of institutional investors in the last quarter, including Ergoteles LLC, Bank of Montreal Can, Citigroup Inc., Qube Research & Technologies Ltd, Goldman Sachs Group Inc., State Street Corp, Renaissance Technologies LLC, and BlackRock Inc..
View insider buying and selling activity for Metromile or or view top insider-buying stocks.

Shares of MILE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MILE stock can currently be purchased for approximately $0.94.

Metromile (NASDAQ:MILE) has a market capitalization of $122.59 million and generates $104.90 million in revenue each year. The company earns $-216.46 million in net income (profit) each year or ($1.81) on an earnings per share basis.

Metromile employs 384 workers across the globe.

Metromile's mailing address is 425 MARKET STREET #700, SAN FRANCISCO CA, 94105. The official website for Metromile is www.metromile.com. The company can be reached via phone at 888-242-5204 or via email at [email protected].